Skip to content

Author

Gordon B. Mills

We have 1 of 17 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Abstract A133: CASPER: A Phase Ib trial combining calaspargase pegol-mnkl and cobimetinib in pancreatic cancer

A hallmark of PDAC is its ability to reprogram metabolism. A majority of PDAC tumors (50-80%) express low levels of asparagine synthetase (ASNS) rendering them dependent on extracellular asparagine. L-asparaginase (ASNase) depletes systemic asparagine to restrict tumor cell growth, but clinical trials of ASNase i...

Lyndsey Sandow, Adel Kardosh, Emerson Y. Chen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.